Literature DB >> 11351034

Atrial natriuretic factor increases splenic microvascular pressure and fluid extravasation in the rat.

R Sultanian1, Y Deng, S Kaufman.   

Abstract

The spleen is an important site of atrial natriuretic factor (ANF)-induced fluid extravasation into the systemic lymphatic system. The mechanism underlying this process was studied in a blood-perfused (1 ml min(-1)) rat spleen using the double occlusion technique. To ensure that our observations were spleen specific, a similar protocol was repeated in the hindquarters. Rat ANF(1-28), infused into the splenic artery of anaesthetized male rats, caused a dose-dependent (0.3-59 pmol min(-1)) increase in microvascular pressure from 11.3 +/- 0.7 to 14.9 +/- 0.5 mmHg and in post-capillary resistance from 7.2 +/- 0.6 to 10.1 +/- 1.1 mmHg ml(-1). ANF elicited no change in splenic pre-capillary resistance or in hindquarter haemodynamics. Intrasplenic ANF (6.5 pmol min(-1)) caused a sustained increase in intrasplenic fluid efflux from 0.1 +/- 0.1 to 0.3 +/- 0.1 ml min(-1), and in capillary filtration coefficient (Kf) from 1.2 +/- 0.5 to 2.4 +/- 0.6 ml mmHg-1 min-1 (100 g tissue)-1. Mechanical elevation of splenic intravascular pressure (from 11.3 +/- 0.7 to 22.4 +/- 0.2 mmHg) significantly increased intrasplenic fluid extravasation (from 0.4 +/- 0.3 to 1.4 +/- 0.3 ml min(-1)). The natriuretic peptide receptor-C (NPRC)-specific agonist C-ANF(4-23) (12.5 and 125 pmol min(-1)) did not alter splenic intravascular pressure or pre-/post-capillary resistance. The ANF antagonist A71915 (8.3 and 83 pmol min-1), which blocks ANF-stimulated cGMP production via natriuretic peptide receptor-A (NPRA), inhibited the ANF-induced changes in splenic microvascular pressure and post-capillary resistance. It is concluded that ANF enhances the extravasation of isoncotic fluid from the splenic vasculature both by raising intrasplenic microvascular pressure (increased post-capillary resistance) and by increasing filtration area. The constrictive activity of ANF on the splenic vasculature is mediated through NPRA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11351034      PMCID: PMC2278622          DOI: 10.1111/j.1469-7793.2001.0273b.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  32 in total

1.  Physiological role of silent receptors of atrial natriuretic factor.

Authors:  T Maack; M Suzuki; F A Almeida; D Nussenzveig; R M Scarborough; G A McEnroe; J A Lewicki
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

2.  Atrial natriuretic peptide, ANP(99-126), receptors in rat thymocytes and spleen cells.

Authors:  M Kurihara; S Katamine; J M Saavedra
Journal:  Biochem Biophys Res Commun       Date:  1987-06-15       Impact factor: 3.575

3.  Validation of double vascular occlusion method for Pc,i in lung and skeletal muscle.

Authors:  M I Townsley; R J Korthuis; B Rippe; J C Parker; A E Taylor
Journal:  J Appl Physiol (1985)       Date:  1986-07

Review 4.  Innervation and vascular pharmacodynamics of the mammalian spleen.

Authors:  F D Reilly
Journal:  Experientia       Date:  1985-02-15

5.  A new method for estimating intestinal capillary pressure.

Authors:  D N Granger; M A Perry; P R Kvietys; A E Taylor
Journal:  Am J Physiol       Date:  1983-03

6.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

Authors:  A J de Bold; H B Borenstein; A T Veress; H Sonnenberg
Journal:  Life Sci       Date:  1981-01-05       Impact factor: 5.037

7.  Atrial natriuretic factor decreases whole-body capillary absorption in rats.

Authors:  N C Trippodo; R W Barbee
Journal:  Am J Physiol       Date:  1987-05

8.  Morphology of the human and dog spleen with special reference to intrasplenic microcirculation.

Authors:  K Takubo; H Miyamoto; M Imamura; T Tobe
Journal:  Jpn J Surg       Date:  1986-01

Review 9.  Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.

Authors:  S A Atlas; M Volpe; R E Sosa; J H Laragh; M J Camargo; T Maack
Journal:  Fed Proc       Date:  1986-06

10.  Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney.

Authors:  M Marin-Grez; J T Fleming; M Steinhausen
Journal:  Nature       Date:  1986 Dec 4-10       Impact factor: 49.962

View more
  6 in total

1.  Effects of atrial natriuretic peptide on the extrasplenic microvasculature and lymphatics in the rat in vivo.

Authors:  Zoë L S Brookes; Susan Kaufman
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

2.  Constriction of rat extra-splenic veins to lipopolysaccharide involves endothelin-1.

Authors:  Arnaud Mansart; Lewis J Ruff; Mark P Ariaans; Jonathan J Ross; Charles S Reilly; Nicola J Brown; Susan Kaufman; Zoë L S Brookes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-16       Impact factor: 3.000

3.  Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide.

Authors:  Karim Sabrane; Markus N Kruse; Larissa Fabritz; Bernd Zetsche; Danuta Mitko; Boris V Skryabin; Melanie Zwiener; Hideo A Baba; Masashi Yanagisawa; Michaela Kuhn
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

4.  Adrenomedullin increases fluid extravasation from the splenic circulation of the rat.

Authors:  S Kaufman; P Andrew; R Sultanian; Y Deng
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

Review 5.  Right Heart Failure and Cardiorenal Syndrome.

Authors:  Thida Tabucanon; Wai Hong Wilson Tang
Journal:  Cardiol Clin       Date:  2020-03-02       Impact factor: 2.213

6.  Influence of Social Isolation During Prolonged Simulated Weightlessness by Hindlimb Unloading.

Authors:  Candice G T Tahimic; Amber M Paul; Ann-Sofie Schreurs; Samantha M Torres; Linda Rubinstein; Sonette Steczina; Moniece Lowe; Sharmila Bhattacharya; Joshua S Alwood; April E Ronca; Ruth K Globus
Journal:  Front Physiol       Date:  2019-09-13       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.